Tuesday, September 1, 2026

Understand What Goes Into a New Drug Submission

Date & Time

Sep 10, 2026

2:00 PM - 4:00 PM (EST)


How is the Workshop delivered?

Live. Virtual. Interactive. Instructor-led.

NDS Submissions Explained: Where Applications Break Down

Greetings!


Every new drug approval begins with understanding the regulatory pathway.


From drug development and pre-submission meetings to CTD preparation, filing and regulatory review, bringing a new drug to market involves a structured process with specific requirements at every stage.


This workshop provides a practical introduction to that process and the regulatory framework behind it.


Participants will explore:

  • How the drug development and approval process works
  • The fundamentals of New Drug Submissions (NDS)
  • Notice types and Health Canada’s Priority Review Policy
  • The role of pre-submission meetings
  • Submission formatting, filing and screening
  • The structure and purpose of the Common Technical Document (CTD)
  • Key CTD modules and their role in a submission
  • How eCTD can streamline the regulatory submission process


Designed for professionals entering Regulatory Affairs, as well as those in Quality, Drug Development and the pharmaceutical industry who want to strengthen their understanding of the submission and approval process.


Build the regulatory foundation behind successful drug submissions.



*All participants will receive a Certificate of Attendance upon completion.

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web

When an NDS Gets More Complex

Date & Time

Oct 1, 2026

2:00 PM - 4:00 PM (EST)


How is the Workshop delivered?

Live. Virtual. Interactive. Instructor-led.

NDS Level 2: Practical CTD and eCTD Preparation for Drug Product Submissions

Greetings!


Knowing the CTD structure is one thing. Managing a complex submission is another.


As an NDS moves through preparation and review, regulatory professionals need to connect quality, nonclinical and clinical documentation, manage the eCTD lifecycle, and respond effectively when Health Canada raises questions or deficiencies.


NDS Level 2: Practical CTD and eCTD Preparation for Drug Product Submissions takes participants beyond the fundamentals and into the practical challenges involved in preparing and managing advanced drug submissions.


Through detailed instruction and real-world case studies, participants will learn how to:

  • Prepare advanced content across CTD Modules 3, 4 and 5
  • Manage quality, nonclinical and clinical documentation
  • Navigate pre-submission meetings with Health Canada
  • Respond to NODs, NONs and regulatory queries
  • Manage eCTD amendments and submission lifecycles
  • Apply effective cross-referencing, hyperlinking and filing practices
  • Recognize common challenges through real-world NDS case studies


Ideal for Regulatory Affairs, Quality, Clinical Research and pharmaceutical professionals who already understand the fundamentals and are ready to develop more advanced, practical submission skills.


Move beyond understanding the submission. Learn how to manage it.


*All participants will receive a Certificate of Attendance upon completion.

Interested in this workshop?

Register today by calling our team at 416-628-7575 or email us at events@aapspharma.com

LinkedIn  Web